OuchThatHurts
Moderator / Psy, Ret.
Staff member
Moderator
Kilo Klub Member
Registered
Verified Customer
- Joined
- Nov 6, 2005
- Messages
- 10,537
Some of this many of you already know but for those that don't, this is a solid method for maximizing energy levels during workouts without the need for stimulants. It can also give you an outline for insulin and L-carnitine timing. I thought I'd put this together for ketos and carb lovers alike (I love both).
As we all should know by now, L-Carnitine facilitates very well the transport of long-chain fatty acids into mitochondria for β-oxidation, producing acetyl-CoA, which enters the tricarboxylic acid (TCA) cycle to generate ATP. This process is critical during states of high fat oxidation, such as fasting, prolonged or heavy exercise, or low-carbohydrate conditions. This makes a good injectable L-carn like Synthetine a must for keto people.
While L-carn promotes fatty acid oxidation, insulin (e.g., Humalog, R[regular], etc) obviously massively promotes glucose uptake by upregulating glucose transporter type 4 (GLUT4) in muscle and fat cells, driving glucose into cells for glycolysis. The glycolysis then produces pyruvate, which is converted to acetyl-CoA in mitochondria for ATP production via the TCA cycle. Insulin also suppresses fat oxidation by inhibiting lipolysis and promoting glucose storage as glycogen OR FAT. Yes, fat.
Glucose/fatty acid competition? Well, sure.
Mitochondrial energy usage refers to the organelle’s capacity to process substrates (acetyl-CoA from glucose or fatty acids) through the TCA cycle and oxidative phosphorylation to produce ATP. Competition could occur if L-carnitine-driven fatty acid oxidation and insulin-driven glucose metabolism compete for mitochondrial resources (e.g., enzymes, coenzymes like CoA, or electron transport chain capacity).
Here’s how this may play out:
1. Substrate Competition (Acetyl-CoA Pool):
Both fatty acid oxidation (via L-carnitine) and glucose oxidation (via insulin-driven glucose uptake) produce acetyl-CoA, which feeds into the TCA cycle. If mitochondrial capacity to process acetyl-CoA is limited (e.g., during high metabolic demand), an abundance of one substrate (fatty acids or glucose) could theoretically outcompete the other for entry into the TCA cycle.
Insulin strongly favors glucose metabolism by activating pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA, and suppressing carnitine palmitoyltransferase-1 (CPT-1), the enzyme L-carnitine interacts with to transport fatty acids into mitochondria. High insulin levels could therefore reduce L-carnitine’s ability to drive fatty acid oxidation, potentially limiting its mitochondrial contribution.
2. Metabolic Flexibility:
Your cells exhibit metabolic flexibility when you can switch between glucose and fatty acid oxidation based on substrate availability and hormonal signals. High insulin levels (e.g. post-insulin injection) shift metabolism toward glucose oxidation, downregulating fatty acid oxidation. This creates a scenario where L-carnitine’s role in mitochondrial energy production is suppressed, as insulin prioritizes glucose over fats.
Conversely, in low-insulin states (e.g., fasting or exercise), L-carnitine’s role in fatty acid oxidation becomes more prominent. If injectable L-carnitine significantly increases fatty acid transport into mitochondria, it could theoretically compete with glucose-derived pyruvate for mitochondrial processing.
3. Coenzyme A (CoA) Availability:
Both pathways rely on CoA to form acetyl-CoA. L-Carnitine also uses CoA to form acylcarnitine complexes during fatty acid transport. If CoA availability is limited, high L-carnitine activity could reduce free CoA for glucose metabolism, and vice versa.
4. Energy Demand and Mitochondrial Capacity:
During high energy demand (e.g., intense exercise), mitochondria may prioritize the substrate that is most abundant or hormonally favored. Insulin drives rapid glucose uptake, potentially saturating mitochondrial pathways with glucose-derived acetyl-CoA. If L-carnitine is simultaneously increasing fatty acid oxidation, the two pathways might compete for TCA cycle and electron transport chain capacity, especially in metabolically stressed states.
Injectable L-Carnitine and insulin: Specific Considerations
Pharmacokinetics:
• Injectable L-carnitine rapidly increases plasma and tissue L-carnitine levels, potentially enhancing fatty acid oxidation more than oral supplementation. Humalog, as one example, peaks within 1–2 hours, strongly promoting glucose uptake and oxidation. Their concurrent use could create a metabolic tug-of-war, with insulin favoring glucose and suppressing L-carnitine’s fatty acid transport via CPT-1 inhibition.
• Timing and Context: The degree of competition depends on timing. If insulin is administered during a high-carbohydrate meal, glucose metabolism will dominate, potentially overriding L-carnitine’s effects. In contrast, during fasting or low-carb states (keto), L-carnitine’s role in fat oxidation could take precedence, especially if insulin levels are low.
This keeps your mitochondria eating both fats and glucose with great metabolic flexibility and great for long-term health. This will all depend on your diet. This is why I never mix fats and carbs as any excess of one or the other will be stored as fat. You may not win any trophies using this method but your body will thank you and you'll always have ATP on tap.
As we all should know by now, L-Carnitine facilitates very well the transport of long-chain fatty acids into mitochondria for β-oxidation, producing acetyl-CoA, which enters the tricarboxylic acid (TCA) cycle to generate ATP. This process is critical during states of high fat oxidation, such as fasting, prolonged or heavy exercise, or low-carbohydrate conditions. This makes a good injectable L-carn like Synthetine a must for keto people.
While L-carn promotes fatty acid oxidation, insulin (e.g., Humalog, R[regular], etc) obviously massively promotes glucose uptake by upregulating glucose transporter type 4 (GLUT4) in muscle and fat cells, driving glucose into cells for glycolysis. The glycolysis then produces pyruvate, which is converted to acetyl-CoA in mitochondria for ATP production via the TCA cycle. Insulin also suppresses fat oxidation by inhibiting lipolysis and promoting glucose storage as glycogen OR FAT. Yes, fat.
Glucose/fatty acid competition? Well, sure.
Mitochondrial energy usage refers to the organelle’s capacity to process substrates (acetyl-CoA from glucose or fatty acids) through the TCA cycle and oxidative phosphorylation to produce ATP. Competition could occur if L-carnitine-driven fatty acid oxidation and insulin-driven glucose metabolism compete for mitochondrial resources (e.g., enzymes, coenzymes like CoA, or electron transport chain capacity).
Here’s how this may play out:
1. Substrate Competition (Acetyl-CoA Pool):
Both fatty acid oxidation (via L-carnitine) and glucose oxidation (via insulin-driven glucose uptake) produce acetyl-CoA, which feeds into the TCA cycle. If mitochondrial capacity to process acetyl-CoA is limited (e.g., during high metabolic demand), an abundance of one substrate (fatty acids or glucose) could theoretically outcompete the other for entry into the TCA cycle.
Insulin strongly favors glucose metabolism by activating pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA, and suppressing carnitine palmitoyltransferase-1 (CPT-1), the enzyme L-carnitine interacts with to transport fatty acids into mitochondria. High insulin levels could therefore reduce L-carnitine’s ability to drive fatty acid oxidation, potentially limiting its mitochondrial contribution.
2. Metabolic Flexibility:
Your cells exhibit metabolic flexibility when you can switch between glucose and fatty acid oxidation based on substrate availability and hormonal signals. High insulin levels (e.g. post-insulin injection) shift metabolism toward glucose oxidation, downregulating fatty acid oxidation. This creates a scenario where L-carnitine’s role in mitochondrial energy production is suppressed, as insulin prioritizes glucose over fats.
Conversely, in low-insulin states (e.g., fasting or exercise), L-carnitine’s role in fatty acid oxidation becomes more prominent. If injectable L-carnitine significantly increases fatty acid transport into mitochondria, it could theoretically compete with glucose-derived pyruvate for mitochondrial processing.
3. Coenzyme A (CoA) Availability:
Both pathways rely on CoA to form acetyl-CoA. L-Carnitine also uses CoA to form acylcarnitine complexes during fatty acid transport. If CoA availability is limited, high L-carnitine activity could reduce free CoA for glucose metabolism, and vice versa.
4. Energy Demand and Mitochondrial Capacity:
During high energy demand (e.g., intense exercise), mitochondria may prioritize the substrate that is most abundant or hormonally favored. Insulin drives rapid glucose uptake, potentially saturating mitochondrial pathways with glucose-derived acetyl-CoA. If L-carnitine is simultaneously increasing fatty acid oxidation, the two pathways might compete for TCA cycle and electron transport chain capacity, especially in metabolically stressed states.
Injectable L-Carnitine and insulin: Specific Considerations
Pharmacokinetics:
• Injectable L-carnitine rapidly increases plasma and tissue L-carnitine levels, potentially enhancing fatty acid oxidation more than oral supplementation. Humalog, as one example, peaks within 1–2 hours, strongly promoting glucose uptake and oxidation. Their concurrent use could create a metabolic tug-of-war, with insulin favoring glucose and suppressing L-carnitine’s fatty acid transport via CPT-1 inhibition.
• Timing and Context: The degree of competition depends on timing. If insulin is administered during a high-carbohydrate meal, glucose metabolism will dominate, potentially overriding L-carnitine’s effects. In contrast, during fasting or low-carb states (keto), L-carnitine’s role in fat oxidation could take precedence, especially if insulin levels are low.
This keeps your mitochondria eating both fats and glucose with great metabolic flexibility and great for long-term health. This will all depend on your diet. This is why I never mix fats and carbs as any excess of one or the other will be stored as fat. You may not win any trophies using this method but your body will thank you and you'll always have ATP on tap.
